|
|
Volumn 4, Issue 1, 2005, Pages 56-59
|
|
Combination of Peginterferon alpha-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B- an Indian experience.
a
a
BOMBAY HOSPITAL
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA2B INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PEGINTERFERON ALFA-2B;
PEGINTERFERON ALPHA2B;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEMALE;
HEPATITIS B;
HUMAN;
INDIA;
LIVER FUNCTION TEST;
MALE;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
ANTIVIRAL AGENTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
INDIA;
INTERFERON ALFA-2B;
LAMIVUDINE;
LIVER FUNCTION TESTS;
MALE;
PROSPECTIVE STUDIES;
REVERSE TRANSCRIPTASE INHIBITORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
|
EID: 18344376194
PISSN: 16652681
EISSN: None
Source Type: Journal
DOI: 10.1016/s1665-2681(19)32087-3 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
